Published in
BMJ Publishing Group, Annals of the Rheumatic Diseases, 10(80), p. e159-e159, 2021
DOI: 10.1136/annrheumdis-2021-220539
BMJ Publishing Group, Annals of the Rheumatic Diseases, 10(80), p. e160-e160, 2021
DOI: 10.1136/annrheumdis-2021-220736
BMJ Publishing Group, Annals of the Rheumatic Diseases, 10(80), p. e158-e158, 2021
DOI: 10.1136/annrheumdis-2021-220496
Links
Tools
Correspondence on ‘Immunogenicity and safety of anti-SARS-Cov-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort’
Journal article published in 2021 by
Larissa Valor-Méndez 
,
Bobby Zuniga,
Li Zhou,
Jesse Veenstra,
Jie Wang,
Giuseppe A. Ramirez,
Koray Tascilar,
David Simon ,
Emanuel Della-Torre,
Kathleen McKinnon-Maksimowicz,
Chiara Salviani ,
Joerg Distler,
Luca Moroni,
Tingting Liu,
Francesco Scolari
and other authors.
,
Bobby Zuniga,
Li Zhou,
Jesse Veenstra,
Jie Wang,
Giuseppe A. Ramirez,
Koray Tascilar,
David Simon ,
Emanuel Della-Torre,
Kathleen McKinnon-Maksimowicz,
Chiara Salviani ,
Joerg Distler,
Luca Moroni,
Tingting Liu,
Francesco Scolari
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 